Medication info

OmniPf Plus One Ferry Injection

Prescription medicationInjections
Ingredient · strength
L-Alanine›0.652g / 100mLL-Arginine›0.362g / 100mLGlycine›0.324g / 100mLL-Histidine›0.151g / 100mLL-Isoleucine›0.189g / 100mLL-Leucine›0.23g / 100mLL-Lysine Hydrochloride›0.228g / 100mLL-Methionine›0.126g / 100mLL-Phenylalanine›0.176g / 100mLL-Proline›0.214g / 100mLL-Serine›0.158g / 100mLTaurine›0.032g / 100mLL-Threonine›0.132g / 100mLL-Tryptophan›0.057g / 100mLL-Tyrosine›0.013g / 100mLL-Valine›0.183g / 100mLCalcium Chloride Hydrate›0.023g / 100mLSodium Glycerophosphate Pentahydrate›0.186g / 100mLMagnesium Sulfate Heptahydrate›0.078g / 100mLPotassium Chloride›0.141g / 100mLSodium Acetate Hydrate›0.177g / 100mLZinc Sulfate Heptahydrate›0.0007g / 100mLGlucose Monohydrate›7.78g / 100mLSoybean Oil›0.564g / 100mLTriglycerides Medium-Chain›0.564g / 100mLPurified Olive Oil›0.776g / 100mLPurified Fish Oil (High Dose Omega-3 Fatty Acids)›0.917g / 100mL
Manufacturer / importer
HK Inno.N Co., Ltd.
Appearance
It consists of a transparent, colorless injection solution with three compartments divided by a plastic internal bag and an outer package, with an oxygen absorbent in between. Each compartment contains a transparent and colorless to pale yellow amino acid solution.
Packaging
362 mL/bag [A Solution 114 mL, B Solution 197 mL, C Solution 51 mL], 500 mL/bag [A Solution 157.5 mL, B Solution 272 mL, C Solution 70.5 mL], 724 mL/bag [A Solution 228 mL, B Solution 394 mL, C Solution 102 mL], 952 mL/bag [A Solution 300 mL, B Solution 518 mL, C Solution 134 mL], 1448 mL/bag [A Solution 456 mL, B Solution 788 mL, C Solution 204 mL]
Approval status
Active

MFDS item code 202302671 · Approved 2023.09.07 · Insurance code 640007932,640007933,640007934,640007935,

Summary

Main use
Correction of deficiencies in fluids, electrolytes, and nutrients (amino acids, calories, fatty acids, etc.)
Who uses it
Adults · Children
Adult dosage
The dose and infusion rate are determined according to the patient's ability to eliminate fat, metabolize nitrogen and glucose, and nutritional requirements. The dose and bag size are determined according to the patient's condition and body weight. Trace elements, vitamins, electrolytes, etc. may be added depending on the patient's condition. - Patients with normal nutritional status or mild metabolic stress: 0.10-0.15 g/kg/day of nitrogen (0.6-0.9g/kg of amino acids) - Patients experiencing moderate to severe metabolic stress, regardless of nutritional status: 0.15-0.25 g/kg/day of nitrogen (0.9-1.6 g/kg of amino acids) In very special cases (e.g., burns or a marked anabolic state), nitrogen requirements may be higher. Dose A daily dose of 19-38 mL/kg of this medicine provides 0.10-0.20 g/kg of nitrogen (0.6-1.2 g/kg of amino acids) and a total of 13-26kcal/kg (11-21 kcal/kg of non-protein calories). This meets the requirements of most patients. In obese patients, the dose should be based on predicted normal body weight. Infusion rate The infusion rate should not exceed 3.0 mL/kg per hour (equivalent to 0.21g/kg of glucose, 0.10g/kg of amino acids, and 0.08g/kg of fat per hour). The recommended infusion duration is 14-24 hours. Maximum daily dose The maximum daily dose depends on the patient's clinical condition and may vary from day to day. The recommended maximum daily dose is 40mL/kg. The recommended maximum daily dose of 40mL/kg provides 0.21g/kg of nitrogen (amino acids1.3g/kg), 2.8g/kg of glucose, 1.1g/kg of fat, and a total of 28 kcal/kg (equivalent to 23 kcal/kg of non-protein calories). Administration Administer by intravenous infusion into a peripheral or central vein.
Children's dosage
Use in children is not recommended.

Ingredients

Manufacturer
HK Inno.N Co., Ltd.

Efficacy & effects

Correction of deficiencies in fluids, electrolytes, and nutrients (amino acids, calories, fatty acids, etc.)

  • Inability to nourish orally or through the gastrointestinal tract
  • insufficient nutrition orally or through the gastrointestinal tract
  • restrictions on oral or gastrointestinal nutrition.
View approved original text

This medicine is used for patients who cannot be adequately nourished orally or through the gastrointestinal tract. It primarily supplies nutrients, including water, electrolytes, amino acids, calories, essential fatty acids, and omega-3 fatty acids, thereby improving the nutritional status of the patient. This helps enhance the patient's physical strength and immunity, aiding in recovery. This drug assists in treating nutritional deficiencies by administering nutrients directly through intravenous infusion.

Dosage and Administration

Adult dosage

The dose and infusion rate are determined according to the patient's ability to eliminate fat, metabolize nitrogen and glucose, and nutritional requirements. The dose and bag size are determined according to the patient's condition and body weight. Trace elements, vitamins, electrolytes, etc. may be added depending on the patient's condition. - Patients with normal nutritional status or mild metabolic stress: 0.10-0.15 g/kg/day of nitrogen (0.6-0.9g/kg of amino acids) - Patients experiencing moderate to severe metabolic stress, regardless of nutritional status: 0.15-0.25 g/kg/day of nitrogen (0.9-1.6 g/kg of amino acids) In very special cases (e.g., burns or a marked anabolic state), nitrogen requirements may be higher. Dose A daily dose of 19-38 mL/kg of this medicine provides 0.10-0.20 g/kg of nitrogen (0.6-1.2 g/kg of amino acids) and a total of 13-26kcal/kg (11-21 kcal/kg of non-protein calories). This meets the requirements of most patients. In obese patients, the dose should be based on predicted normal body weight. Infusion rate The infusion rate should not exceed 3.0 mL/kg per hour (equivalent to 0.21g/kg of glucose, 0.10g/kg of amino acids, and 0.08g/kg of fat per hour). The recommended infusion duration is 14-24 hours. Maximum daily dose The maximum daily dose depends on the patient's clinical condition and may vary from day to day. The recommended maximum daily dose is 40mL/kg. The recommended maximum daily dose of 40mL/kg provides 0.21g/kg of nitrogen (amino acids1.3g/kg), 2.8g/kg of glucose, 1.1g/kg of fat, and a total of 28 kcal/kg (equivalent to 23 kcal/kg of non-protein calories). Administration Administer by intravenous infusion into a peripheral or central vein.

Children's dosage

Use in children is not recommended.

Precautions

This medication must be used strictly under the supervision of a physician and should not be taken or discontinued arbitrarily. If allergic reactions such as fever, chills, rash, or difficulty breathing occur during treatment with this medication, discontinue immediately and consult with medical personnel. Do not mix this medication with intravenous drugs containing calcium; if the same infusion equipment must be used, clean the infusion line thoroughly before and after administration. Particularly in premature or low-birth-weight infants, caution is required as the lipid components of this medication may cause problems in the lungs. Patients with allergies to fish, eggs, soybeans, peanuts, or those with specific liver, kidney, or blood disorders should not use this medication. Patients with severe hyperlipidemia, acute shock, or uncontrolled hyperglycemia should also avoid administration. Patients with severely impaired kidney function or unstable conditions such as acute myocardial infarction or stroke should use this medication cautiously. During administration, blood tests and clinical conditions should be monitored frequently to observe for side effects or adverse reactions, particularly closely monitoring blood triglyceride levels. In cases of overdose, symptoms such as nausea, vomiting, hyperglycemia, and fat overload syndrome may appear, requiring adjustments to the administration rate or discontinuation; if necessary, appropriate treatment should be provided. This medication contains ingredients that may cause allergic reactions, so patients with a history of allergies should exercise caution. The safety of this medication in pregnant or lactating women has not been established; it should be decided carefully after consulting a physician if necessary. During administration, ensure thorough aseptic technique to reduce the risk of infection and confirm that the drug is uniformly mixed prior to administration. This medication should be stored at temperatures between 1 and 25 degrees Celsius, and should be used as soon as possible after mixing.

Side effects

  • Air embolism
  • bowel obstruction
  • paralysis of bowel obstruction
  • constipation
  • nausea
  • phlebitis
  • fever
  • swelling at the injection site
  • edema at the injection site
  • pain at the injection site
Show 31 more
  • pleural effusion
  • atelectasis
  • headache
  • sensory loss
  • back pain
  • falls
  • increased blood bilirubin
  • hypophosphatemia
  • insomnia
  • lipodystrophy syndrome
  • hyperlipidemia
  • fever
  • fat infiltration
  • jaundice
  • hepatomegaly
  • splenomegaly
  • anemia
  • leukopenia
  • thrombocytopenia
  • coagulopathy
  • hemolysis
  • reticulocytosis
  • abnormal liver function test results
  • coma
  • nausea
  • vomiting
  • chills
  • sweating
  • elevated body temperature
  • hyperglycemia
  • allergic reactions

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air and moisture ingress and is best kept at room temperature between 1 and 25 degrees Celsius. This helps maintain the drug's efficacy and prevents degradation.

Appearance and packaging

Appearance

It consists of a transparent, colorless injection solution with three compartments divided by a plastic internal bag and an outer package, with an oxygen absorbent in between. Each compartment contains a transparent and colorless to pale yellow amino acid solution.

Package unit

362 mL/bag [A Solution 114 mL, B Solution 197 mL, C Solution 51 mL], 500 mL/bag [A Solution 157.5 mL, B Solution 272 mL, C Solution 70.5 mL], 724 mL/bag [A Solution 228 mL, B Solution 394 mL, C Solution 102 mL], 952 mL/bag [A Solution 300 mL, B Solution 518 mL, C Solution 134 mL], 1448 mL/bag [A Solution 456 mL, B Solution 788 mL, C Solution 204 mL]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.